Market Place
Sourcing Support
All News #Library
Biotech
Ardelyx Abstract On IBS-C Treatment Patterns Accepted
23 Apr 2026 //
FIRSTWORD PHARMA
Ardelyx Names Rajani Dinavahi, MD, Chief Medical Officer
01 Apr 2026 //
GLOBENEWSWIRE
Ardelyx Reveals 2026 Derek Forfang Patient Advocate Award Winners
12 Mar 2026 //
GLOBENEWSWIRE
Ardelyx Reveals Tenapanor`s Rapid Symptom Relief In IBS-C Review
09 Mar 2026 //
GLOBENEWSWIRE
Ardelyx To Participate In Upcoming Investor Conferences
04 Mar 2026 //
GLOBENEWSWIRE
Ardelyx Reveals 2025 Financials, Business Update
19 Feb 2026 //
GLOBENEWSWIRE
Ardelyx to Release 2025 Full-Year Results on Feb. 19
05 Feb 2026 //
GLOBENEWSWIRE
Ardelyx Receives New Patent For Tenapanor
03 Feb 2026 //
GLOBENEWSWIRE
First Patient Dosed in Phase 3 ACCEL Study of IBSRELA
28 Jan 2026 //
GLOBENEWSWIRE
XPHOZAH Data Shows Patient Satisfaction And Phosphate Drop
07 Nov 2025 //
GLOBENEWSWIRE
Ardelyx To Present at Jefferies Global Healthcare Conference
05 Nov 2025 //
GLOBENEWSWIRE
Ardelyx Ceo Raab To Join Wedbush Rewind ASN 2025 Meeting
04 Nov 2025 //
GLOBENEWSWIRE
Ardelyx Shows IBSRELA Benefits At ACG 2025 Meeting
28 Oct 2025 //
GLOBENEWSWIRE
Ardelyx To Present Four Abstracts At ASN`s Kidney Week
21 Oct 2025 //
GLOBENEWSWIRE
Ardelyx`s Review Article of IBS-C in Clinical Gastroenterology
09 Oct 2024 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.